Pei Gong Li
Direttore/Membro del Consiglio presso Huzhou Shenke Biotechnology Co., Ltd.
Profilo
Pei Gong Li is an Independent Director who worked at Xiamen Yanjan New Material Co., Ltd.
from 2015 to 2021.
Currently, Dr. Li holds the position of Independent Director at Huzhou Shenke Biotechnology Co., Ltd.
since 2022.
Posizioni attive di Pei Gong Li
| Società | Posizione | Inizio |
|---|---|---|
Huzhou Shenke Biotechnology Co., Ltd.
 Huzhou Shenke Biotechnology Co., Ltd. BiotechnologyHealth Technology Huzhou Shenke Biotechnology Co., Ltd. engages in the research and development, production, and sale of professional testing tools and services for quality control of biological products. Its main products are quality control[special kits, special equipment and consumables, and testing and customized development services. The company was founded on February 3, 2012 and is headquartered in Huzhou, China. | Direttore/Membro del Consiglio | 01/12/2022 |
Precedenti posizioni note di Pei Gong Li
| Società | Posizione | Fine |
|---|---|---|
| XIAMEN YANJAN NEW MATERIAL CO., LTD. | Direttore/Membro del Consiglio | 28/06/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| XIAMEN YANJAN NEW MATERIAL CO., LTD. | Process Industries |
| Aziende private | 1 |
|---|---|
Huzhou Shenke Biotechnology Co., Ltd.
Huzhou Shenke Biotechnology Co., Ltd. BiotechnologyHealth Technology Huzhou Shenke Biotechnology Co., Ltd. engages in the research and development, production, and sale of professional testing tools and services for quality control of biological products. Its main products are quality control[special kits, special equipment and consumables, and testing and customized development services. The company was founded on February 3, 2012 and is headquartered in Huzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Pei Gong Li
